These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21456169)

  • 1. Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
    Pandelidou M; Dimas K; Georgopoulos A; Hatziantoniou S; Demetzos C
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1259-66. PubMed ID: 21456169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
    Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
    PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines.
    Casadó A; Sagristá ML; Mora M
    Int J Nanomedicine; 2018; 13():5301-5320. PubMed ID: 30254436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
    Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines.
    Matsingou C; Dimas K; Demetzos C
    Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
    Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C
    Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
    Li L; Ahmed B; Mehta K; Kurzrock R
    Mol Cancer Ther; 2007 Apr; 6(4):1276-82. PubMed ID: 17431105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
    Shnaikat SG; Shakya AK; Bardaweel SK
    Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
    Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
    Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery.
    Radha R; Paul V; Anjum S; Bouakaz A; Pitt WG; Husseini GA
    Sci Rep; 2024 May; 14(1):10499. PubMed ID: 38714740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid liposomal PEGylated calix[4]arene systems as drug delivery platforms for curcumin.
    Drakalska E; Momekova D; Manolova Y; Budurova D; Momekov G; Genova M; Antonov L; Lambov N; Rangelov S
    Int J Pharm; 2014 Sep; 472(1-2):165-74. PubMed ID: 24954662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
    Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
    Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
    Kolter M; Wittmann M; Köll-Weber M; Süss R
    Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
    Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
    Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
    Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
    Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
    Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
    J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.